GOLGA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.117400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.374200E-01
Normal-vs-Stage2
1.360830E-01
Normal-vs-Stage3
7.440800E-01
Normal-vs-Stage4
1.750250E-01
Stage1-vs-Stage2
9.657000E-01
Stage1-vs-Stage3
4.127000E-01
Stage1-vs-Stage4
3.783000E-01
Stage2-vs-Stage3
1.971440E-01
Stage2-vs-Stage4
9.431800E-02
Stage3-vs-Stage4
1.657830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.141600E-01
Normal-vs-AfricanAmerican
4.112000E-01
Normal-vs-Asian
3.194800E-01
Caucasian-vs-AfricanAmerican
4.714200E-01
Caucasian-vs-Asian
6.926600E-01
AfricanAmerican-vs-Asian
6.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.222840E-01
Normal-vs-Female
3.008600E-01
Male-vs-Female
9.220200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.292600E-01
Normal-vs-Age(41-60Yrs)
1.889240E-01
Normal-vs-Age(61-80Yrs)
2.179400E-01
Normal-vs-Age(81-100Yrs)
1.705590E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.973800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.235800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.858200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.572100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.563600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.453400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.641400E-01
Normal-vs-Daily Drinker
2.906000E-01
Normal-vs-Weekly Drinker
2.232200E-01
Normal-vs-Occasional Drinker
9.306000E-02
Normal-vs-Social Drinker
3.812400E-01
Non Drinker-vs-Daily Drinker
9.301600E-01
Non Drinker-vs-Weekly Drinker
6.851000E-01
Non Drinker-vs-Occasional Drinker
1.149610E-01
Non Drinker-vs-Social Drinker
2.789000E-01
Daily Drinker-vs-Weekly Drinker
5.965800E-01
Daily Drinker-vs-Occasional Drinker
8.065900E-02
Daily Drinker-vs-Social Drinker
2.611800E-01
Weekly Drinker-vs-Occasional Drinker
2.946400E-01
Weekly Drinker-vs-Social Drinker
3.802400E-01
Occasional Drinker-vs-Social Drinker
7.172400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.919800E-01
Normal-vs-Grade 2
6.174000E-01
Normal-vs-Grade 3
6.225400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.282600E-01
Grade 1-vs-Grade 3
9.636200E-01
Grade 1-vs-Grade 4
4.919800E-01
Grade 2-vs-Grade 3
9.206000E-01
Grade 2-vs-Grade 4
6.174000E-01
Grade 3-vs-Grade 4
6.225400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.954600E-01
Normal-vs-NonDiabetic
2.431400E-01
Diabetic-vs-NonDiabetic
1.681790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.202000E-01
Normal-vs-NoPancreatitis
2.400800E-01
Pancreatitis-vs-NoPancreatitis
7.218600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.698000E-01
Normal-vs-N1
1.169160E-01
N0-vs-N1
8.048800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.940000E-02
Normal-vs-TP53-NonMutant
3.147200E-01
TP53-Mutant-vs-TP53-NonMutant
5.325900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
